Oatmeal Health Launches AI Platform for Lung Cancer Screening

What You Ought to Know: 

– Oatmeal Health, an innovator in AI-driven most cancers screening launches its AI-powered radiology danger stratification platform for lung most cancers. 

– The answer offers a completely reimbursable second-opinion diagnostic device lined by Medicare, making it extra accessible and reasonably priced for healthcare suppliers and sufferers.

AI-Powered Lung Nodule Evaluation

Lung most cancers stays a number one reason for cancer-related deaths worldwide, however screening charges stay alarmingly low. Oatmeal Well being’s platform goals to deal with this problem by leveraging AI to reinforce the accuracy and effectivity of lung most cancers screening, significantly in underserved communities.

Oatmeal Well being’s platform makes use of cutting-edge AI and laptop imaginative and prescient to investigate 3D low-dose CT scans, robotically detecting, analyzing, and categorizing lung nodules based mostly on their danger profile. This expertise streamlines workflows, reduces diagnostic errors, and empowers healthcare suppliers with actionable insights to help well timed interventions.

How It Works

1. Information Ingestion: The platform ingests CT scan knowledge, identifies areas of curiosity, and encodes nodule-level and scan-level options.
2. Deep Studying Evaluation: Information is processed via Oatmeal Well being’s proprietary deep studying framework, that includes convolutional neural networks (CNNs) optimized for 3D imaging.
3. Danger Stratification: Superior computer-aided detection (CADe) and analysis (CADx) methodologies guarantee correct danger stratification, complementing established protocols like Lung-RADS.

Educated on a various dataset of over 100,000 CT scans, Oatmeal Well being’s platform boasts distinctive accuracy, with an AUROC of 0.94, validating its reliability in real-world medical settings.

Driving Constructive Change in Lung Most cancers Care

Oatmeal Well being’s platform has demonstrated vital success in pilot applications, reaching a 90% affected person conversion fee for telemedicine-based shared decision-making visits. The corporate is actively partaking with healthcare suppliers, payers, and policymakers to speed up AI adoption and enhance lung most cancers outcomes.

“Our mission is obvious: to democratize entry to life-saving most cancers screening applied sciences, significantly in communities that want it most,” stated Jonathan Govette, CEO of Oatmeal Well being. “By leveraging AI and specializing in underserved populations, we’re not simply bettering screening charges—we’re saving lives and setting a brand new commonplace for equitable healthcare.”